Picture supply: Getty Photographs
FTSE 250 world funding agency abrdn (LSE: ABDN) has had a horrible 12 months.
It was demoted from the FTSE 100 on the finish of August 2023. This occurred as a result of the shares had fallen 15% within the yr to that time, lowering its market capitalisation by 25%.
The relegation robotically triggered a wave of contemporary promoting from funds unable to carry non-FTSE 100 shares.
And in a 24 January buying and selling replace, it stated it’s slicing 500 jobs to assist cut back prices by £150m.
Nonetheless, though I hardly ever purchase shares outdoors the FTSE 100 both, a number of issues enchantment to me about abrdn proper now.
Severe ex-appeal
One among them is that this isn’t the primary time abrdn has been relegated from the FTSE 100 to the FTSE 250. It occurred a yr earlier than as effectively.
Within the run-up to its earlier demotion, its shares tumbled. They then crashed when the relegation announcement was made official in August 2022.
The corporate then minimize some prices as it’s doing now and added totally different income streams.
It was then promoted again to the FTSE 100 simply 4 months later, and its shares spiked again up once more.
The present spherical of cost-cutting is deep and appears lengthy overdue. In keeping with the corporate, it can take away layers of administration — at all times a great factor for my part.
It can additionally outsource extra know-how, which mustn’t simply cut back prices however improve operational effectivity, I feel.
With overheads diminished, the corporate ought to be capable of pump more cash into its newest income turbines.
Its 2022 acquisition of interactive investor was the important thing driver for abrdn’s 4% rise in working income in H1 2023, for instance.
The acquisition of Tekla Capital Administration’s healthcare funds additionally appears promising. US healthcare expenditure per capita has grown at a compound annual price of 6% because the Nineteen Eighties.
Consensus analyst expectations are actually for abrdn’s earnings to rise by 89% a yr till the top of 2026.
One threat within the inventory is that this enterprise reorganisation would possibly fail. One other is that it won’t be capable of appeal to new web inflows into its funds.
Doubly undervalued in opposition to its friends
The automated devaluation of abrdn after the FTSE 100 demotion, has left its shares undervalued on two key measures.
On a price-to-book ratio (P/B) foundation, it trades at simply 0.5 – the bottom in its peer group, the common P/B of which is 2.9.
The peer group includes Caledonia Investments (at 0.6), Bridgepoint Group (2.7), St. James’s Place (2.8), and Hargreaves Lansdown (5.3).
On a price-to-sales ratio (P/S) foundation, abrdn trades at 1.9 in opposition to a peer group common of 5.8. St. James’s Place is at 0.3, Hargreaves Lansdown at 5.1, Bridgepoint Group at 6.7, and Caledonia Investments at 10.9.
Due to this fact, on each measurements, abrdn may be very undervalued relative to its friends.
I already maintain a number of shares within the monetary sector, so shopping for extra would unbalance my portfolio.
If I didn’t, I’d in all probability purchase abrdn now each for its development potential and for its undervalued shares.
No less than as interesting as these is its large yield – at present simply over 9%. This is likely one of the very highest in both the FTSE 250 or FTSE 100.
